##plugins.themes.bootstrap3.article.main##

Enrique Damián Gil-Guevara Ramiro Diaz Carlos Bermudez

Abstract

Introduction and objectives. Fetal obstructive uropathy can be treated early in pregnancy by intrauterine vesicoamniotic
shunting, immediately after being diagnosed by ultrasound, in specific cases with a favorable prognosis in renal function using
fetal urinary beta-2 microglobuline. The main objective of the study was to determine the changes of beta-2 microglobuline
in consecutive samples of fetal urine in 48 – 72 hour-intervals in fetuses with obstructive uropathy at 16 weeks of gestation.
Methods. We performed a descriptive and longitudinal study, including 15 pregnant women whose fetuses were diagnosed
with obstructive uropathy and without chromosomal abnormalities, performing vesicocentesis for urinary biometry.

Downloads

Download data is not yet available.

##plugins.themes.bootstrap3.article.details##

Section
Originals articles

How to Cite

Gil-Guevara, E. D., Diaz, R., & Bermudez, C. (2017). Prognostic Value Of Fetal Urinary Beta-2 Microglobuline In Vesicoamniotic Shunting Therapy For Fetal Obstructive Uropathy. Revista Peruana De Investigación Materno Perinatal, 6(1), 9–16. https://doi.org/10.33421/inmp.201771